PerkinElmer is "highly interested" in investing in its cell-based assay and reagent businesses, and will likely attempt to acquire core competencies in these areas through acquisitions, partnerships, or both in the coming year, a PerkinElmer official told BioCommerce Week's sister publication Cell-Based Assay News at the Society for Biomolecular Screening conference in Geneva last week.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.